Young Adult Medical Cannabis Patients in Florida: Gender Differences in Characteristics of use,Experiences at Dispensaries,and Association With Health-Related Problems

Abstract

In recent years there has been an increase in cannabis use among adults in the U.S., which corresponds with changes in state-level laws making cannabis available for medical/recreational use. While cannabis became available for medical use in Florida in 2014, it was not until a ban on smoking cannabis was lifted in 2019 that the number of patients began to increase. The data for the current study are the Florida Young Adult Cannabis Study and focus on 415 medical cannabis patients (MCP). We identified several significant differences between male and female MCP. Female MCP initiated regular cannabis use at a younger age and reported more frequent cannabis use. Female MCP were more likely to endorse self-treatment motives while male MCP were more likely to endorse recreational motives. As Florida is one of the largest and most diverse states in the U.S., research on MCP is needed to inform policy.

Keywords

cannabis use dispensary medical cannabis sex/gender

Get full access to this article

View all access options for this article.

References

Costales

Bommel-Wegmen

Winterstein

Richard

(2021). Clinical Conditions and prescription drug Utilization among early medical marijuana Registrants in Florida . Journal of psychoactive Drugs , 53(3), 185–194. https://doi.org/10.1080/02791072.2020.1864069

Allen

H. R.

Boudreaux

Keller

J. N.

(2020). Comparison of male and female patients in Louisiana medical marijuana dispensaries. Journal of Clinical Medicine, 9(6), 1865. https://doi.org/10.3390/jcm9061865

Azofeifa

Sherman

L. J.

Mattson

M. E.

Pacula

R. L.

(2018). Marijuana buyers in the United States, 2010–2014. Drug and Alcohol Dependence, 183, 34–42. https://doi.org/10.1016/j.drugalcdep.2017.10.019

Bertakis

K. D.

Azari

Helms

L. J.

Callahan

E. J.

Robbins

J. A.

(2000). Gender differences in the utilization of health care services. Journal of Family Practice, 49, 147.

Boehnke

K. F.

Ryan Scott, J., Litinas, E., Sisley, S., Clauw, D. J., Goesling, J., & Williams, D. A . (2019). Cannabis use preference and decision-making among a cross-sectional cohort of medical cannabis patients with chronic pain. Journal of Pain, 20, 1362–1372.

Bohnert

K. M.

Bonar

E. E.

Arnedt

J. T.

Conroy

D. A.

Walton

M. A.

Ilgen

M. A.

(2018). Utility of the comprehensive marijuana motives questionnaire among medical cannabis patients. Addictive Behaviors, 76, 139–144. https://doi.org/10.1016/j.addbeh.2017.08.001

Bonn-Miller

M. O.

Boden

M. T.

Bucossi

M. M.

Babson

K. A.

(2014). Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users. The American Journal of Drug and Alcohol Abuse, 40(1), 23–30. https://doi.org/10.3109/00952990.2013.821477

Brown

J. D.

Costales

van Boemmel-Wegmann

Goodin

A. J.

Segal

Winterstein

A. G.

(2020). Characteristics of older adults who were early adopters of medical cannabis in the Florida Medical Marijuana Use Registry. Journal of Clinical Medicine, 9(4), 1166. http://doi.10.3390/jcm9041166

Bruce

Grove

T. J.

Foster

Shattell

(2021). Gender differences in medical cannabis use: Symptoms treated, physician support for use, and prescription medication discontinuation. Journal of Women’s Health, 30, 857–863.

10.

Buckner

J. D.

Zvolensky

M. J.

Mayorga

N. A.

Abarno

C. N.

Hopper

Garey

(2020). Cannabis use among dual electronic and combustible cigarette smokers: Relations with pain and hazardous drinking. Substance Use & Misuse, 55, 1677–1682. https://doi.org/10.1080/10826084.2020.1756852

11.

Calcaterra

S. L.

Cunningham, C. O., & Hopfer, C. J . (2020). The void in clinician counseling of cannabis use. Journal of General Internal Medicine, 35, 1875–1878.

12.

Center for Behavioral Health Statistics and Quality . (2021). Results from the 2020 national survey on drug use and health: Detailed tables. Substance Abuse and Mental Health Services Administration.

13.

Cunradi

C. B.

Caetano

Alter

H. J.

Ponicki

W. R.

(2020). Adverse childhood experiences are associated with at-risk drinking, cannabis and illicit drug use in females but not males: An emergency department study. American Journal of Drug and Alcohol Abuse, 46, 739–748. https://doi.org/10.1080/00952990.2020.1823989

14.

Daniulaityte

Zatreh

M. Y.

Lamy

F. R.

Nahhas

R. W.

Martins

S. S.

Sheth

Carlson

R. G.

(2018). A twitter-based survey on marijuana concentrate use. Drug and Alcohol Dependence, 187, 155–159.

15.

Fairman

B. J.

(2015). Trends in registered medical marijuana participation across 13 US states and District of Columbia. Drug and Alcohol Dependence, 159, 72–79. https://doi.org/10.1016/j.drugalcdep.2015.11.015

16.

Gossop

Best

Marsden

Strang

(1997). Test-retest reliability of the severity of dependence scale. Addiction, 92, 353.

17.

Halladay

J. E.

Boyle

M. H.

Munn

Jack

S. M.

Georgiades

(2019). Sex differences in the association between cannabis use and suicidal ideation and attempts, depression, and psychological distress among Canadians. Canadian Journal of Psychiatry: Revue Canadienne de Psychiatrie, 64, 345–350. https://doi.org/10.1177/0706743718804542

18.

Haug

N. A.

Padula

C. B.

Sottile

J. E.

Vandrey

Heinz

A. J.

Bonn-Miller

M. O.

(2017). Cannabis use patterns and motives: A comparison of younger, middle-aged, and older medical cannabis dispensary patients. Addictive Behaviors, 72, 14–20. https://doi.org/10.1016/j.addbeh.2017.03.006

19.

Heen

Lieberman

J. D.

Miethe

T. D.

(2014). A comparison of different online sampling approaches for generating national samples. Center for Crime and Justice Policy, 1, 1–8.

20.

Hemsing

Greaves

(2020). Gender norms, roles, and relations and cannabis-use patterns: A scoping review. International Journal of Environmental Research and Public Health, 17, 141–240. https://doi.org/10.3390/ijerph17030947

21.

Johnston

L. D.

O’Malley

P. M.

(1985). Issues of validity and population coverage in student surveys of drug use. NIDA Research Monograph, 57, 31–54.

22.

Kepple

N. J.

Freisthler

(2018). Who’s buying what and how much? Correlates of purchase behaviors from medical marijuana dispensaries in los angeles, California. The Journal of Primary Prevention, 39(6), 571–589. https://doi.org/10.1007/s10935-018-0528-5

23.

Kruger

D. J.

Kruger

J. S.

(2019). Medical cannabis users’ comparisons between medical cannabis and mainstream medicine. Journal of Psychoactive Drugs, 51(1), 31–36. https://doi.org/10.1080/02791072.2018.1563314

24.

Lankenau

Ataiants

Mohanty

Schrager

Iverson

Wong

C. F.

(2018). Health conditions and motivations for marijuana use among young adult medical marijuana patients and non-patient marijuana users. Drug and Alcohol Review, 37(2), 237–246. https://doi.org/10.1111/dar.12534

25.

Lankenau

Fedorova

E. V.

Reed

Schrager

S. M.

Iverson

Wong

C. F.

(2016). Marijuana practices and patterns of use among young adult medical marijuana patients and non-patient marijuana users. Drug and Alcohol Dependence, 170, 181–188. https://doi.org/10.1016/j.drugalcdep.2016.10.025

26.

Leung

Chan

Stjepanovic

Chung

J. Y. C.

Hall

Hammond

(2022). Prevalence and self-reported reasons for cannabis use for medical purposes in USA and Canada. Psychopharmacology, 239, 1509–1519.

27.

Lin

L. A.

Ilgen

M. A.

Jannausch

Bohnert

K. M.

(2015). Comparing adults who use cannabis medically with those who use recreationally: Results from a national sample. Addictive Behaviors, 61, 99–103. https://doi.org/10.1016/j.addbeh.2016.05.015

28.

Lucas

Walsh

(2017). Medical cannabis access, use, and substitution for prescription opioids and other substances: A survey of authorized medical cannabis patients. The International Journal of Drug Policy, 42, 30–35. https://doi.org/10.1016/j.drugpo.2017.01.01

29.

Luque

J. S.

Okere

A. N.

Reyes-Ortiz

C. A.

Williams

P. M.

(2021). Mixed methods study of the potential therapeutic benefits from medical cannabis for patients in Florida. Complementary Therapies in Medicine, 57(102669), 307. https://doi.org/10.1016/j.ctim.2021.102669

30.

Mahabir

V. K.

Smith

C. S.

Vannabouathong

Jamil

Garibaldi

A. L.

(2021). Comparing medical cannabis use in 5 us states: A retrospective database study. Journal of Cannabis Research, 3(15). https://doi.org/10.1186/s42238-021-00075-z

31.

Manuel

J. I.

(2018). Racial/ethnic and gender disparities in health care use and access. Health Services Research, 53, 1407–1429.

32.

Mauro

C. M.

Newswanger, P., Santanella-Tenoriom J., Mauro, P. M., Carliner, H., & Martins, S. S . (2019). Impact of medical marijuana laws on state-level marijuana use by age and gender, 2004-2013. Prevention Science, 5, 205–214.

33.

Merlin

J. S.

Althouse, A., Feldman, R., Arnsten, J. H., Bulls, H. W., Liebshutz, J. M., Nugent, S. M., Orris, S. R., Rohac, R., Starrels, J. L., Morasco, B. J., & Kansagara, D . (2021). Analysis of state cannabis laws and dispensary staff recommendations to adults purchasing medical cannabis. JAMA Network Open, 4, e2124511.

34.

Morean

M. E.

Lederman

I. R.

(2019). Prevalence and correlates of medical cannabis patients' use of cannabis for recreational purposes. Addictive Behaviors, 93, 233–239. https://doi.org/10.1016/j.addbeh.2019.02.003

35.

Nunberg

Kilmer

Pacula

R. L.

Burgdorf

J. R.

(2011). An analysis of applicants presenting to a medical marijuana specialty practice in California. Journal of Drug Policy Analysis, 4(1), 1–16. https://doi.10.2202/1941-2851.1017

36.

O’Connell

T. J.

Bou-Matar

C. B.

(2007). Long term marijuana users seeking medical cannabis in California (2001-2007): Demographics, social characteristics, patterns of cannabis and other drug use of 4117 applicants. Harm Reduction Journal, 4(1), 16–16. https://doi.org/10.1186/1477-7517-4-16

37.

O’Malley

P. M.

Bachman

J. G.

Johnston

L. D.

(1983). Reliability and consistency in self-reports of drug use. International Journal on Addiction, 18, 805–824.

38.

Park

(2017). Prevalence, reasons, perceived effects, and correlates of medical marijuana use: A review. Drug and Alcohol Dependence, 177, 1–13.

39.

Prather

A. A.

Gottlieb

L. M.

Giuse

N. B.

Koonce

T. Y.

Kusnoor

S. V.

Stead

W. W.

Adler

N. E.

(2017). National academy of medicine social and behavioral measures: Associations with self-reported health. American Journal of Preventive Medicine, 53, 449–456. https://doi.org/10.1016/j.amepre.2017.02.010

40.

Reed

Kioumarsi, A., Ataiants, J., Fedorova, E. V., Iverson, E., Wong, C. F., & Lankenau, S. E . (2020). Marijuana sources in a medical marijuana environment: Dynamics in access and use among a cohort of young adults in Los Angeles, CA. Drugs: Education, Prevention, and Policy, 27, 69–78.

41.

Reiman

(2009). Cannabis as a substitute for alcohol and other drugs. Harm Reduction Journal, 6(1), 35–35. https://doi.org/10.1186/1477-7517-6-35

42.

Reiman

Welty

Solomon

(2017). Cannabis as a substitute for opioid-based pain medication: Patient self-report. Cannabis and Cannabinoid Research, 2(1), 16–166. https://doi.org/10.1089/can.2017.0012

43.

Reinarman

Nunberg

Lanthier

Heddleston

(2011). Who are medical marijuana patients? Population characteristics from nine California assessment clinics. Journal of Psychoactive Drugs, 43(2), 128–135. https://doi.org/10.1080/02791072.2011.587700

44.

Rosenthal

M. S.

Pipitone

R. N.

(2021). Demographics, perceptions, and use of medical marijuana among patients in Florida. Medical Cannabis and Cannabinoids, 4(1), 13–20. https://doi.org/10.1159/000512342

45.

Ryan-Ibarra

Induni

Ewing

(2015). Prevalence of medical marijuana use in California, 2012. Drug and Alcohol Review, 34(2), 141–146. https://doi.org/10.1111/dar.12207

46.

Schepis

T. S.

Desai, R. A., Cavallo, D. A., Smith, A. E., McFetridge, A., Liss, T. B., Potenza, M. N., & Krishnan-Sarin, S. (2011). Gender differences in adolescent marijuana use and psychosocial characteristics. Journal of Addiction Medicine, 5, 65–73.

47.

Troutt

W. D.

DiDonato

M. D.

(2015). Medical cannabis in Arizona: Patient characteristics, perceptions, and impressions of medical cannabis legalization. Journal of Psychoactive Drugs, 47(4), 259–266. https://doi.org/10.1080/02791072.2015.1074766

48.

Walsh

Callaway

Belle-Isle

Capler

Kay

Lucas

Holtzman

(2013). Cannabis for therapeutic purposes: Patient characteristics, access, and reasons for use. The International Journal of Drug Policy, 24(6), 511–516. https://doi.org/10.1016/j.drugpo.2013.08.010

49.

Walter

S. L.

Seibert

S. E.

Goering

O’Boyle

E. H.

(2018). A tale of two sample sources: Do results from online panel data and conventional data converge? Journal of Business and Psychology, 34, 425–452. https://doi.org/10.1111/ajad.12401

50.

Weiss

K. G.

Dilks

L. M.

(2015). Marijuana, gender, and health-related harms: Disentangling marijuana’s contribution to risk in a college “party” context. Sociological Spectrum, 35, 254–270.

51.

Wen

Hockenberry

J. M.

Druss

B. G.

(2019). The effect of medical marijuana laws on marijuana-related attitude and perception among US adolescents and young adults. Prevention Science, 20(2), 215–223. https://doi.org/10.1007/s11121-018-0903-8

52.

Zaller

Topletz

Frater

Yates

Lally

(2015). Profiles of medicinal cannabis patients attending compassion centers in Rhode Island. Journal of Psychoactive Drugs, 47(1), 18–23. https://doi.org/10.1080/02791072.2014.999901